Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety profile, tolerability, pharmacokinetics
and pharmacodynamics of ascending single doses of BMS-866949 in healthy subjects.